| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | PHA-793887 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | XMD8-92 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.6 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | Camptothecin | GDSC1000 | pan-cancer | AAC | -0.02 | 0.6 |
| mRNA | selumetinib:piperlongumine (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | MGCD-265 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.6 |
| mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.028 | 0.6 |
| mRNA | QL-XII-47 | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |